Business Wire

For Mary Kay, It’s Mission Critical: We’ve Accelerated Our Digital Innovation Efforts to Unleash the Full Potential of Women Entrepreneurs

8.3.2023 21:32:00 EET | Business Wire | Press release

Share

Below is a statement by Deborah Gibbins, Chief Operating Officer, Mary Kay Inc., in celebration of International Women’s Day 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230308005697/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Deborah Gibbins, Mary Kay’s Chief Operating Officer (Photo courtesy: Mary Kay Inc.)

37% of women worldwide do not have access to the internet. I know - I had to read that twice, too.1

37%! The number is staggering. It feels impossible. In our always-on, always-connected world, how can more than a third of all women in the world remain “unconnected”? This shocking reality - and its implications - fuel this year’s International Women’s Day theme: “DigitALL: Innovation and technology for gender equality.”

As Chief Operating Officer at Mary Kay, I know the role technology plays in all aspects of business – especially entrepreneurial business. To maximize the opportunity offered by technology, digital literacy skills are an absolute requirement for women entrepreneurs to fully participate in our global economy. They are also a necessity for civic and social engagement.

The foundations for the Fourth Industrial Revolution are digital and they are being laid right now. For all of us this revolution holds the tremendous opportunity to leverage technology and innovation to advance women entrepreneurship and equality. The time is now to ensure women reap the benefits of this digital transformation.

The digital economy won’t wait for anyone to catch up. Women’s exclusion from the digital world has shaved $1 trillion from the gross domestic product of low- and middle-income countries in the last decade.2 Once again, change is not happening fast enough for women.

We can fix this. We must fix this.

To reach their full potential, women business owners around the world must not only have access to the digital tools we take for granted, but they must have the right skills and training to use them effectively.

That’s why bridging the digital gender gap is so personal to us at Mary Kay, a company founded by a woman for women.

Our founder, Mary Kay Ash, had a vision to offer women unmatched entrepreneurial opportunities for advancement and personal success. That means something different today than it did in the ‘60s, but that same spirit remains. As an entrepreneurship development company, our focus is lifting women entrepreneurs up and addressing the barriers they face in establishing or growing their business. Digitalization is one of them.

At Mary Kay, we are determined to put women entrepreneurs at the center of the digital transformation.

We’ve accelerated our digital innovation efforts – this includes revolutionizing Mary Kay’s Independent Beauty Consultants’ (IBCs) ability to unleash their full potential through digital upskilling, the development and roll-out of innovative digital tools, from award-winning apps featuring augmented reality (AR), to connecting IBCs with their customers in more effective and seamless ways. We’re improving not only the experience for the independent sales force, but for their customers around the world.

Here are some of the latest examples of our commitment to empower Mary Kay’s independent sales force to harness the power of digital:

  • In Europe, our award-winning “Link & Learn” is an integrated education platform comprising a robust learning curriculum IBCs can access anytime, anywhere. This self-paced, interactive learning system helps consultants put their dreams into action by providing a competency-based curriculum with relevant, expert-driven content while connecting them with a community of like-minded consultants. It includes content focused on the key areas of competency that are essential for success at each step of the career path. With this content, consultants strategically focus on key topics and acquire skills such as Selling Skills, Business Skills, Product Knowledge and Understanding the Mary Kay Way. Mary Kay has received numerous awards for this educational platform, including a coveted gold ranking in the Education category in the “2019 Spring Omni Awards.” In 2021 Mary Kay Poland received the “Innovative Company” award for the program from the Home & Market magazine, and in 2018 it was awarded a “Technology Excellence Award” from the Brandon Hall Group.
  • The InTouch® platform is a one-stop shop mobile platform which provides millions of IBCs around the world 24-hour access to information, and services to effectively manage their Mary Kay business. It includes many features to enhance their knowledge of the beauty industry through product education, basic business skills through marketing and sales tools, and a professional network. With this app, IBCs can access product ingredient information and material to share with their customers or as a quick reference.
  • The Salesforce.com platform has also recently been rolled out to our Mary Kay markets via the Mary Kay InTouch site, enabling a more seamless use of digital technology in day-to-day operations, including placing orders. IBCs receive 24/7 support from their local Mary Kay teams and save time to focus on tasks that add more value to their business.
  • Mary Kay Mirror Me™ is our real-time makeover app using augmented reality to apply makeup trends and color products for real life application. After finding their perfect look, customers can add products to their shopping bag and connect with an IBC. Mirror Me™ is available in the North America, Europe and Latin America regions.
  • Mary Kay® Skin Analyzer is a tool that brings skin care and technology together at one’s fingertips. It helps customers understand the unique characteristics of their skin and create a customized skin care routine and is available in the North America, Asia-Pacific and Latin America regions.
  • And finally, the newly launched Mary Kay Interactive Catalog brings Mary Kay catalogs to life with easy product ordering, GIFs, videos, shareable wish lists, instant augmented reality makeovers and more. The catalog is available in the North America, Europe and Latin America regions.

We also believe in digital collaborations to help women entrepreneurs harness the power of digital throughout the world. To this end, we have joined forces with:

And we’re just getting started. The digital revolution is underway. Let’s not miss out on this golden opportunity to enable women and girls to champion entrepreneurship in the digital age!

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in more than 35 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn or follow us on Twitter.

1 ITU (2022). Facts and Figures 2022 - The gender digital divide (itu.int)

2 UN Women. Progress on the Sustainable Development Goals. The Gender Snapshot 2022.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc.
media@mkcorp.com
+1-972-687-5332

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye